propranolol has been researched along with Alveolar Bone Atrophy in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"Low doses of propranolol suppress bone resorption by inhibiting RANKL-mediated osteoclastogenesis as well as inflammatory markers without affecting haemodynamic parameters." | 5.38 | Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. ( Barbosa-Neto, O; Clemente-Napimoga, JT; da Silva, TA; Dias-da-Silva, VJ; Lopes, AH; Madeira, MF; Miguel, CB; Napimoga, MH; Rodrigues, WF, 2012) |
"Propranolol was given in high (20 mg/kg/day) and low (10 mg/kg/day) doses via osmotic pumps." | 5.29 | The effect of propranolol on salivary gland function and dental caries development in young and aged rats. ( Bowen, WH; O'Connell, AC; Pearson, SK; Van Wuyckhuyse, BC, 1993) |
"Low doses of propranolol suppress bone resorption by inhibiting RANKL-mediated osteoclastogenesis as well as inflammatory markers without affecting haemodynamic parameters." | 1.38 | Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. ( Barbosa-Neto, O; Clemente-Napimoga, JT; da Silva, TA; Dias-da-Silva, VJ; Lopes, AH; Madeira, MF; Miguel, CB; Napimoga, MH; Rodrigues, WF, 2012) |
"Periodontal disease is characterised by alveolar bone loss." | 1.36 | Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model. ( Hamada, N; Kim, Y; Okada, Y; Ozono, S; Sasaguri, K; Sato, S; Takahashi, Y, 2010) |
"Propranolol was given in high (20 mg/kg/day) and low (10 mg/kg/day) doses via osmotic pumps." | 1.29 | The effect of propranolol on salivary gland function and dental caries development in young and aged rats. ( Bowen, WH; O'Connell, AC; Pearson, SK; Van Wuyckhuyse, BC, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okada, Y | 1 |
Hamada, N | 1 |
Kim, Y | 1 |
Takahashi, Y | 1 |
Sasaguri, K | 1 |
Ozono, S | 1 |
Sato, S | 1 |
Shimizu, Y | 1 |
Hosomichi, J | 1 |
Kaneko, S | 1 |
Shibutani, N | 1 |
Ono, T | 1 |
Rodrigues, WF | 1 |
Madeira, MF | 1 |
da Silva, TA | 1 |
Clemente-Napimoga, JT | 1 |
Miguel, CB | 1 |
Dias-da-Silva, VJ | 1 |
Barbosa-Neto, O | 1 |
Lopes, AH | 1 |
Napimoga, MH | 1 |
O'Connell, AC | 1 |
Van Wuyckhuyse, BC | 1 |
Pearson, SK | 1 |
Bowen, WH | 1 |
4 other studies available for propranolol and Alveolar Bone Atrophy
Article | Year |
---|---|
Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model.
Topics: Acid Phosphatase; Adrenergic beta-Antagonists; Alveolar Bone Loss; Alveolar Process; Animals; Bacter | 2010 |
Effect of sympathetic nervous activity on alveolar bone loss induced by occlusal hypofunction in rats.
Topics: Adrenergic beta-Antagonists; Alveolar Bone Loss; Alveolar Process; Animals; Bone Density; Bone Marro | 2011 |
Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
Topics: Acid Phosphatase; Alveolar Bone Loss; Animals; Bone Resorption; Cathepsin K; Cell Differentiation; C | 2012 |
The effect of propranolol on salivary gland function and dental caries development in young and aged rats.
Topics: Aging; Alveolar Bone Loss; Animals; Dental Caries; Dental Caries Susceptibility; Dental Plaque; Diet | 1993 |